Clinical imaging is essentialelement of the expensive research and development method of biotechnology and pharmaceuticalindustries. The usage of medical imaging is established in clinicaltrials, for making trials more accurate and effective. Clinical trial imaging brings information of human physiology /anatomy, changeable from incontestable interpretable information to information which is of uncertain value. The image presenting long fractured bone is basically understood rather than a sharing of uncharacterized ligand receptor in cerebral cortex is meaningless. The clinical assumptions of an image areessential in evaluating the medicine effect. Clinical imaging is used on daily base to manage, prevent, treat, detect, and various diseases or medical conditions.
How Big is the Global Clinical Trial Imaging Market?
The clinical trial imaging market is expected to exceed more than US$ 1545 million by 2028 at CAGR 6.5% in given forecast period.
The major driving factors of global clinical trial imaging market are as follows:
The restraining factors of global clinical trial imaging market are as follows:
The Global clinical trial imaging market is segmented on the lines of itsproducts, modality, end users and regional. The products are further segmented into software and services.Based on services segmentation it covers into system and technology, reader service, operational imaging services and design consulting. The modality market is classified intoX ray, PET, CT, MRI, ultrasound, echo and others. The CT has the main share in the clinical trial imaging market. End users segmented into academic and government research institutes, medical devices manufacturers, biopharmaceutical companies, CROs and others. Theclinical trial imaging marketon geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
This report provides:
1) An overview of the global market for global clinical trial imaging market and related technologies.
2) Analyses of global market trends, with data from 2021, estimates for 2022 and 2023, and projections of compound annual growth rates (CAGRs) through 2028.
3) Identifications of new market opportunities and targeted promotional plans for global clinical trial imaging market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
REPORT SCOPE:
The scope of the report includes a detailed study of global and regional markets Global clinical trial imagingmarket with the reasons given for variations in the growth of the industry in certain regions.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include BioClinica Inc, Cardiovascular Imaging Technologies, ICON plc, Biomedical Systems, Intrinsic Imaging LLC, PAREXEL International Corporation, VirtualScopic Inc and Prism Clinical Imaging. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
The Top Companies Report is intended to provide our buyers with a snapshot of the industry’s most influential players.
The Global Clinical trial imaging Market has been segmented as below:
By Product Segment Analysis
By Modality Analysis
By End-user Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
Reasons to Buy this Report:
1) Obtain the most up to date information available on all globalclinical trial imaging market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of global clinical trial imaging market data.
4) Assess your competitor’s refining portfolio and its evolution.
Customization:
We can offer you custom research reports as per client’s special requirements.
1 INTRODUCTION
1.1 Key Take Aways
1.2 Report Description
1.3 Markets Covered
1.4 Stakeholders
1.5 Research Methodology
1.5.1 Market Size
1.5.2 Market Share
1.5.3 Key Data Points From Secondary Sources
1.5.4 Key Data Points From Primary Sources
2 Research Methodology
2.1 Market Size Estimation
2.2 Market Breakdown and Data Triangulation
2.3 Market Rank Estimation
2.3.1 Key Data From Secondary Sources
2.3.2 Key Data From Primary Sources
2.3.3 Key Industry Insights
2.3.4 Assumptions for The Study
3 Executive Summary
4 Premium Insights
4.1 Clinical Trial Imaging: Market Overview
4.2 Clinical Trial Imaging Market, By Product & Service, 2019
4.3 Clinical Trial Imaging Market Size, By Modality, 2019 vs 2025
4.4 Clinical Trial Imaging Market Size, By End User, 2019 vs 2025
4.5 Geographic Snapshot of The Clinical Trial Imaging Market
4.6 Life Cycle Analysis, By Region
5 Market Overview
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increase in R&D Spending
5.2.1.2 Growth in The Pharmaceutical and Biotechnology Industries
5.2.1.3 Increasing Number of Cros
5.2.2 Restraints
5.2.2.1 High Implementation Cost of Imaging Systems
5.2.3 Opportunities
5.2.3.1 Emerging Economies
5.2.3.2 Development of Innovative Imaging Modalities, Contrast Agents, Molecular Probes, and Radiopharmaceuticals
5.2.4 Challenges
5.2.4.1 High Cost of Clinical Trials
5.2.4.2 High Cost of Pet
5.3 Recent Market Trends
5.3.1 Rising Demand for Multimodality Imaging Technology in Clinical Trials
5.4 Regulatory Scenario
5.5 Clinical Trials: Global Scenario
6 Clinical Trial Imaging Market, By Product and Service
6.1 Introduction
6.2 Services
6.2.1 Operational Imaging Services
6.2.2 Read Analysis Services
6.2.3 System and Technical Support Services
6.2.4 Trial Design Consulting Services
6.3 Software
7 Clinical Trial Imaging Market, By Modality
7.1 Introduction
7.2 Computed Tomography
7.3 Magnetic Resonance Imaging
7.4 Ultrasound
7.5 Positron Emission Tomography
7.6 X-Ray
7.7 Echocardiography
7.8 Other Modalities
8 Clinical Trial Imaging Market, By End User
8.1 Introduction
8.2 Pharmaceutical Companies
8.3 Biotechnology Companies
8.4 Medical Device Manufacturers
8.5 Contract Research Organizations
8.6 Academic and Government Research Institutes
8.7 Other End Users
9 Clinical Trial Imaging Market, By Region
9.1 Introduction
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.4 Asia
9.5 Rest of The World (RoW)
10 Competitive Landscape
10.1 Introduction
10.2 Strategic Overview
10.3 Competitive Situation and Trends
10.4 Leading Players in The Clinical Trial Imaging Market
10.4.1 Agreements, Collaborations, and Partnerships
10.4.2 Expansion
10.4.3 Acquisition
10.4.4 Product and Service Launches & Product Upgrades
11 Company Profiles
11.1 Introduction
11.2 Bioclinica, Inc.
11.3 Parexel International Corporation
11.4 Icon PLC
11.5 Biomedical Systems Corporation
11.6 Biotelemetry, Inc.
11.7 Cardiovascular Imaging Technologies, LLC
11.8 Intrinsic Imaging LLC
11.9 Ixico PLC
11.10 Radiant Sage LLC
11.11 Worldcare Clinical, LLC
The Global Clinical trial imaging Market has been segmented as below:
By Product Segment Analysis
By Modality Analysis
By End-user Analysis
By Regional Analysis
North America
Europe
Asia-Pacific
Rest of the World
